We are live on ! Find out more
REVBU

Revelation Biosciences, Inc. Unit
REVBU

Delisted

REVBU was delisted on the 11th of January, 2023.

Back to rankings

4 hedge funds and large institutions have $11.1M invested in Revelation Biosciences, Inc. Unit in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more capital invested

Capital invested by funds: $10.9M → $11.1M (+$251K)

0% more funds holding

Funds holding: 4 → 4 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
+$28.4K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$10.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
GCL
1
Glazer Capital LLC
New York
$11M – – –
WAM
2
Wolverine Asset Management
Illinois
$82K +$28.4K +2,687 +55%
CFN
3
Cordasco Financial Network
Florida
$53K – – –
UBS Group
4
UBS Group
Switzerland
$3K -$10.5K -999 -79%

REVBU Hedge Fund Activity: Q2 2021 in Review

4 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences, Inc. Unit (REVBU) for Q2 2021, worth a combined $11.1M — up 2.3% from $10.9M a quarter earlier.

Fund positioning in REVBU was balanced in Q2 2021: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Wolverine Asset Management, adding an estimated $28.4K. The largest seller was UBS Group, cutting an estimated $10.5K.

  • 4 institutional investors held Revelation Biosciences, Inc. Unit (REVBU) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $11.1M of Revelation Biosciences, Inc. Unit stock for Q2 2021, up 2.3% quarter-over-quarter.
  • 0 funds opened new Revelation Biosciences, Inc. Unit positions in Q2 2021 and 0 closed out.
  • The largest Revelation Biosciences, Inc. Unit buyer in Q2 2021 was Wolverine Asset Management, an estimated $28.4K added.
  • The largest Revelation Biosciences, Inc. Unit seller in Q2 2021 was UBS Group, an estimated $10.5K sold.

Based on aggregated 13F filings for Q2 2021.